Toxic Anterior Segment Syndrome With Intracameral Moxifloxacin
Published 2024 - 42nd Congress of the ESCRS
Reference: PO376 | Type: Poster | DOI: 10.82333/6qja-w458
Authors: Hazem Elnashar* 1
1Consultant of Ophthalmology,Vice Dean of The Memorial Institute for Ophthalmic Research,GIZA,Egypt
Purpose
to show that high dose of intracameral moxifloxacin can cause TASS even if it is preservative free
Setting
The memorial institute for ophthalmic research (MIOR)
Methods
A 60 y old female presented drop of vision in left eye , after examination I decided to do cataract surgery under local anaesthesia for her. the patient underwent routine phacoemulsification and insertion of a single-piece acrylic intraocular lens implant (IOL) (Acrysof) Intracameral preservative-free moxifloxacin (Vigamox) was used at the end of the case (I noticed that the total volume I injected was 0.5 cc which is large dose than usual ). 1st day post –op I found very sever inflammation , the fluid in the eye was dark , aggressive membranes in AC and around IOL , vision was HM mild pain, no chemosis . U/S showed completely free post seg. So I decided to fu without interference .
Results
I found the same pic in the 2nd day so I diagnosed the patient as TASS and I decided to do AC wash and started to review literature about the causes of TASS and I found that Intracameral Moxifloxacin can cause this .the patient continued on very high doses of topical steroids
The patient started to improve and to took about 4 months until complete resolve of ant seg occurred leaving large areas of iris depigmentation , very week pupillary reaction , dense PCO and high IOP . I continued on anti glaucoma until IOP controlled and did YAG capsulotomy and the final UCVA reached 0.6 that improve by glasses to 0.8
Conclusions
High dose of intracameral moxifloxacin can cause TASS even if it is preservative free
We should differentiate between endophthmitis and TASS